Pressure injectable Jugular Axillo-Subclavian Central CThe CG+Arrow… — Class II medical device recall Z-2267-2017
Terminated recall by Arrow International Inc, reported 2017-06-14, distributed nationwide. Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury f
| Recall number | Z-2267-2017 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Arrow International Inc, Reading, PA, United States |
| Recall initiated | 2017-03-20 |
| Classified | 2017-06-06 |
| Reported by FDA | 2017-06-14 |
| Terminated | 2018-12-18 |
| Distributed | Nationwide (US) |
| Quantity | 43,394 units |
Product
Pressure injectable Jugular Axillo-Subclavian Central CThe CG+Arrow JACC powered by Arrow VPS Stylet permits venous access to the central circulation through a central veinatheter (JACC) Product
Reason for recall
Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2267-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.